Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Promyelocytic, Acute 27Leukemia, Myeloid, Acute 27Leukemia 16Myelodysplastic Syndromes 13Multiple Myeloma 9Neuroblastoma 5Melanoma 5Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Pancreatic Neoplasms 4Neoplasm Metastasis 4Myeloproliferative Disorders 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myelomonocytic, Acute 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Hematologic Neoplasms 4Congenital Abnormalities 4Uterine Cervical Neoplasms 3Leukemia, Myelomonocytic, Chronic 3Anemia, Refractory, with Excess of Blasts 3Thrombocytopenia 2Small Cell Lung Carcinoma 2Prostatic Neoplasms 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pathologic Complete Response 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2

Interventions

Tamoxifen 4Exercise 3pyrotinib 2abemaciclib 2Paclitaxel 2Metformin 2Letrozole 2Cyclophosphamide 2Control Groups 2Capecitabine 2Bupivacaine 2Aromatase Inhibitors 2pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1palbociclib 1iniparib 1exemestane 1durvalumab 1darolutamide 1Yoga 1Waiting Lists 1Vitamin D 1Tumor Burden 1Tretinoin 1Trastuzumab 1Tocopherols 1Thioctic Acid 1Surveys and Questionnaires 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Cancer Female × Tretinoin × Clear all
NCT05016349 2021-08-23

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

Kafrelsheikh University

Phase 3 Unknown
160 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡